Dodge & Cox reports 10.5% stake in GE HealthCare

Dodge & Cox filed an amended Schedule 13G reporting beneficial ownership of 47,334,058 shares of GE HealthCare Technologies Inc. common stock, representing 10.5% of the class.

Accepted by SEC EDGAR 08/07/2026 - 01:41 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Dodge & Cox filed an amended Schedule 13G reporting beneficial ownership of 47,334,058 shares of GE HealthCare Technologies Inc. common stock, representing 10.5% of the class. Dodge & Cox has sole voting power over 44,872,703 shares and sole dispositive power over all 47,334,058 shares, with no shared voting or dispositive power.

The filing states that clients of Dodge & Cox have the right to receive or direct dividends and sale proceeds for these shares. Dodge & Cox Stock Fund, a registered investment company, holds an interest in 30,726,266 shares, equal to 6.8% of the common stock class reported.

Key Figures

Beneficial ownership: 47,334,058 shares Percent of class: 10.5% Sole voting power: 44,872,703 shares +3 more

6 metrics

Beneficial ownership 47,334,058 shares Total GE HealthCare common stock beneficially owned by Dodge & Cox

Percent of class 10.5% Portion of GE HealthCare common stock class owned by Dodge & Cox

Sole voting power 44,872,703 shares Shares for which Dodge & Cox has sole power to vote or direct the vote

Sole dispositive power 47,334,058 shares Shares for which Dodge & Cox has sole power to dispose or direct disposition

Dodge & Cox Stock Fund holding 30,726,266 shares GE HealthCare shares held by Dodge & Cox Stock Fund, a registered investment company

Stock Fund percent of class 6.8% Percent of GE HealthCare common stock class held by Dodge & Cox Stock Fund

Key Terms

beneficially owned, sole voting power, sole dispositive power, Investment Company Act of 1940

4 terms

beneficially owned financial

"Amount beneficially owned: 47,334,058"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole power to vote or to direct the vote: 44,872,703"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole power to dispose or to direct the disposition of: 47,334,058"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Investment Company Act of 1940 regulatory

"investment company registered under the Investment Company Act of 1940"

A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of GEHC common stock does Dodge & Cox report owning?

Dodge & Cox reports beneficial ownership of 47,334,058 GEHC shares, representing 10.5% of the company’s common stock. This ownership is reported on an amended Schedule 13G filing.

How many GEHC shares does Dodge & Cox have sole voting power over?

Dodge & Cox has sole voting power over 44,872,703 GEHC shares. The filing reports no shared voting power, indicating all reported voting authority is held solely by Dodge & Cox.

What is Dodge & Cox’s sole dispositive power position in GEHC?

Dodge & Cox holds sole dispositive power over 47,334,058 GEHC shares and reports no shared dispositive power. This matches the total number of shares it beneficially owns in the filing.

How much of GEHC is held by Dodge & Cox Stock Fund?

Dodge & Cox Stock Fund holds an interest in 30,726,266 GEHC shares, representing 6.8% of the common stock class. It is one of the clients of Dodge & Cox referenced in the ownership disclosure.

Who ultimately benefits from Dodge & Cox’s GEHC share holdings?

The clients of Dodge & Cox, including registered investment companies and other managed accounts, have the right to receive or direct dividends and sale proceeds from the GEHC shares reported.

What type of SEC filing did Dodge & Cox submit for its GEHC stake?

Dodge & Cox submitted an Amendment No. 4 to Schedule 13G for GE HealthCare Technologies Inc. This filing reports beneficial ownership of more than five percent of a registered class of equity securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

GE HEALTHCARE TECHNOLOGIES INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

36266G107

(CUSIP Number)

07/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 36266G107

1

Names of Reporting Persons

Dodge & Cox

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 44,872,703.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 47,334,058.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

47,334,058.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.5 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GE HEALTHCARE TECHNOLOGIES INC.
(b)	Address of issuer's principal executive offices: 500 W. Monroe Street, Chicago, IL 60661
Item 2.
(a)	Name of person filing: Dodge & Cox
(b)	Address or principal business office or, if none, residence: 555 California Street 40th Floor, San Francisco, CA 94104
(c)	Citizenship: California, USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 36266G107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 47,334,058
(b)	Percent of class: 10.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 44,872,703
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 47,334,058
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The clients of Dodge & Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, GE HEALTHCARE TECHNOLOGIES INC. Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940, has an interest of 30,726,266 or 6.8%, of the class of securities reported herein.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dodge & Cox

Signature:	/S/ Katherine M. Primas
Name/Title:	Chief Compliance Officer
Date:	08/07/2026